To sign up for our newsletter or print publications, please enter your contact information below.
Bad News on Anti-HER2 Heart Effects
<![CDATA]>(MedPage Today) — Cardiotoxicity related to trastuzumab (Herceptin) appeared to persist over a median follow-up of 7 years, a small cross-sectional, case-control study indicated. In 22 patients who developed cardiotoxicity…